Risks of imbalanced information on US hospital websites

JAMA Internal Medicine

Volumn 175, Issue 3, 2015, Pages 441-443

  Schenker, Yael ^a   London, Alex John ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOSPITAL INFORMATION SYSTEM; HUMAN; INTERNET; LETTER; MEDICAL DECISION MAKING; MEDICAL INFORMATION; ONLINE SYSTEM; PATIENT DECISION MAKING; PATIENT PREFERENCE; PRIORITY JOURNAL; UNITED STATES; ADVERTIZING; CONSUMER HEALTH INFORMATION; DECISION MAKING; HOSPITAL; RISK; STANDARDS;

ADVERTISING AS TOPIC; CONSUMER HEALTH INFORMATION; DECISION MAKING; HOSPITALS; INTERNET; RISK; UNITED STATES;

EID: 84924049467     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.7400     Document Type: Letter

References (9)

1. Fox S, Duggan M. Health Online 2013. Pew Research Center Internet Project. http://www.pewinternet.org/2013/01/15/health-online-2013/. Accessed October 31, 2014.
2. Kincaid ML, Fleisher LA, Neuman MD. Presentation on US hospital websites of risks and benefits of transcatheter aortic valve replacement procedures [published online January 12, 2015]. JAMA Intern Med. doi:10.1001 /jamainternmed.2014.7392.
3. Larson RJ, Schwartz LM, Woloshin S, Welch HG. Advertising by academic medical centers. Arch Intern Med. 2005; 165(6):645-651.
4. Vater LB, Donohue JM, Arnold R, White D.B., Chu E., Schenker Y. What are cancer centers advertising to the public? a content analysis. Ann Intern Med. 2014; 160(12):813-820.
5. Institute of Medicine. Crossing the Quality Chasm. 2001. http://www.iom.edu/Reports/2001/Crossing-the-Quality-Chasm-A-New-Health-System-for-the-21st-Century.aspx. Accessed October 31, 2014.
6. Schenker Y, Arnold RM, London AJ. The ethics of advertising for health care services. Am J Bioeth. 2014; 14(3):34-43.
7. Stark M, Fins JJ. Engineering medical decisions: computer algorithms and the manipulation of choice. Camb Q Healthc Ethics. 2013; 22(4):373-381.
8. US Department of Health and Human Services, Food and Drug Administration. Guidance for industry: presenting risk information in prescription drug and medical device promotion. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm155480.pdf. Published May 2009. Accessed December 4, 2014.
9. Kravitz RL, Epstein RM, Feldman M.D., et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA. 2005; 293(16):1995-2002.